Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 161

1.

ERS technical standard on bronchial challenge testing: pathophysiology and methodology of indirect airway challenge testing.

Hallstrand TS, Leuppi JD, Joos G, Hall GL, Carlsen KH, Kaminsky DA, Coates AL, Cockcroft DW, Culver BH, Diamant Z, Gauvreau GM, Horvath I, de Jongh FHC, Laube BL, Sterk PJ, Wanger J; American Thoracic Society (ATS)/European Respiratory Society (ERS) Bronchoprovocation Testing Task Force.

Eur Respir J. 2018 Nov 15;52(5). pii: 1801033. doi: 10.1183/13993003.01033-2018. Print 2018 Nov.

PMID:
30361249
2.

Does Size Matter When Calculating the "Correct" Tidal Volume for Pediatric Mechanical Ventilation?: A Hypothesis Based on FVC.

Kim GJ, Newth CJL, Khemani RG, Wong SL, Coates AL, Ross PA.

Chest. 2018 Jul;154(1):77-83. doi: 10.1016/j.chest.2018.04.015. Epub 2018 Apr 22.

PMID:
29684318
3.

Reply to Johnson: Improve Pulmonary Function Test Reporting.

Culver BH, Graham BL, MacIntyre NR, McCormack M, Kaminsky DA, Coates AL, Weiner DJ, Rosenfeld M, Wanger J; ATS Committee on Proficiency Standards for Pulmonary Function Laboratories.

Am J Respir Crit Care Med. 2018 Jul 1;198(1):138-139. doi: 10.1164/rccm.201802-0280LE. No abstract available.

PMID:
29533673
4.

Transducing Airway Basal Cells with a Helper-Dependent Adenoviral Vector for Lung Gene Therapy.

Cao H, Ouyang H, Grasemann H, Bartlett C, Du K, Duan R, Shi F, Estrada M, Seigel KE, Coates AL, Yeger H, Bear CE, Gonska T, Moraes TJ, Hu J.

Hum Gene Ther. 2018 Jun;29(6):643-652. doi: 10.1089/hum.2017.201. Epub 2018 Mar 16.

PMID:
29320887
5.

Recommendations for a Standardized Pulmonary Function Report. An Official American Thoracic Society Technical Statement.

Culver BH, Graham BL, Coates AL, Wanger J, Berry CE, Clarke PK, Hallstrand TS, Hankinson JL, Kaminsky DA, MacIntyre NR, McCormack MC, Rosenfeld M, Stanojevic S, Weiner DJ; ATS Committee on Proficiency Standards for Pulmonary Function Laboratories.

Am J Respir Crit Care Med. 2017 Dec 1;196(11):1463-1472. doi: 10.1164/rccm.201710-1981ST.

PMID:
29192835
6.

ERS technical standard on bronchial challenge testing: general considerations and performance of methacholine challenge tests.

Coates AL, Wanger J, Cockcroft DW, Culver BH; Bronchoprovocation Testing Task Force: Kai-Håkon Carlsen, Diamant Z, Gauvreau G, Hall GL, Hallstrand TS, Horvath I, de Jongh FHC, Joos G, Kaminsky DA, Laube BL, Leuppi JD, Sterk PJ.

Eur Respir J. 2017 May 1;49(5). pii: 1601526. doi: 10.1183/13993003.01526-2016. Print 2017 May.

7.

The PD20 but not the PC20 in a methacholine challenge test is device independent.

Coates AL, Dell SD, Cockcroft DW, Gauvreau GM.

Ann Allergy Asthma Immunol. 2017 Apr;118(4):508-509. doi: 10.1016/j.anai.2017.01.010. Epub 2017 Mar 6. No abstract available.

PMID:
28274734
8.

Magnesium nebulization utilization in management of pediatric asthma (MagNUM PA) trial: study protocol for a randomized controlled trial.

Schuh S, Sweeney J, Freedman SB, Coates AL, Johnson DW, Thompson G, Gravel J, Ducharme FM, Zemek R, Plint AC, Beer D, Klassen T, Curtis S, Black K, Nicksy D, Willan AR; Pediatric Emergency Research Canada Group.

Trials. 2016 May 24;17(1):261. doi: 10.1186/s13063-015-1151-x.

9.

Reference Equations for Spirometry in the Canadian Population.

Coates AL, Wong SL, Tremblay C, Hankinson JL.

Ann Am Thorac Soc. 2016 Jun;13(6):833-41. doi: 10.1513/AnnalsATS.201508-569OC.

PMID:
27088538
10.

Effect of Oxygen Desaturations on Subsequent Medical Visits in Infants Discharged From the Emergency Department With Bronchiolitis.

Principi T, Coates AL, Parkin PC, Stephens D, DaSilva Z, Schuh S.

JAMA Pediatr. 2016 Jun 1;170(6):602-8. doi: 10.1001/jamapediatrics.2016.0114.

PMID:
26928704
11.

Delivery of Epinephrine in the Vapor Phase for the Treatment of Croup.

Leung K, Newth CJ, Hotz JC, O'Brien KC, Fink JB, Coates AL.

Pediatr Crit Care Med. 2016 Apr;17(4):e177-81. doi: 10.1097/PCC.0000000000000666.

PMID:
26910479
13.

Does the FEF25-75 or the FEF75 have any value in assessing lung disease in children with cystic fibrosis or asthma?

Lukic KZ, Coates AL.

Pediatr Pulmonol. 2015 Sep;50(9):863-8. doi: 10.1002/ppul.23234. Epub 2015 Jun 16.

PMID:
26079395
14.

Provocative dose of methacholine causing a 20% drop in FEV1 should be used to interpret methacholine challenge tests with modern nebulizers.

Dell SD, Bola SS, Foty RG, Marshall LC, Nelligan KA, Coates AL.

Ann Am Thorac Soc. 2015 Mar;12(3):357-63. doi: 10.1513/AnnalsATS.201409-433OC.

PMID:
25575246
15.

The Holy See on sexual and reproductive health rights: conservative in position, dynamic in response.

Coates AL, Hill PS, Rushton S, Balen J.

Reprod Health Matters. 2014 Nov;22(44):114-24. doi: 10.1016/S0968-8080(14)44815-8. Review.

16.

Role of spirometry in primary care.

Coates AL, Tamari IE, Graham BL.

Can Fam Physician. 2014 Dec;60(12):1069-70, 1075-7. English, French. No abstract available.

17.

Longitudinal relationship between physical activity and lung health in patients with cystic fibrosis.

Schneiderman JE, Wilkes DL, Atenafu EG, Nguyen T, Wells GD, Alarie N, Tullis E, Lands LC, Coates AL, Corey M, Ratjen F.

Eur Respir J. 2014 Mar;43(3):817-23. doi: 10.1183/09031936.00055513. Epub 2013 Oct 31.

18.

Physiological correlates of pulmonary function in children with cystic fibrosis.

Wells GD, Wilkes DL, Schneiderman JE, Thompson S, Coates AL, Ratjen F.

Pediatr Pulmonol. 2014 Sep;49(9):878-84. doi: 10.1002/ppul.22928. Epub 2013 Oct 25.

PMID:
24166871
19.

Efficient gene delivery to pig airway epithelia and submucosal glands using helper-dependent adenoviral vectors.

Cao H, Machuca TN, Yeung JC, Wu J, Du K, Duan C, Hashimoto K, Linacre V, Coates AL, Leung K, Wang J, Yeger H, Cutz E, Liu M, Keshavjee S, Hu J.

Mol Ther Nucleic Acids. 2013 Oct 8;2:e127. doi: 10.1038/mtna.2013.55.

20.

Aerosolized liposomal Amphotericin B: a potential prophylaxis of invasive pulmonary aspergillosis in immunocompromised patients.

Kamalaporn H, Leung K, Nagel M, Kittanakom S, Calvieri B, Reithmeier RA, Coates AL.

Pediatr Pulmonol. 2014 Jun;49(6):574-80. doi: 10.1002/ppul.22856. Epub 2013 Jul 10.

PMID:
23843366
21.

Respiratory system deposition with a novel aerosol delivery system in spontaneously breathing healthy adults.

Coates AL, Leung K, Chan J, Ribeiro N, Charron M, Schuh S.

Respir Care. 2013 Dec;58(12):2087-92. doi: 10.4187/respcare.02455. Epub 2013 Jun 18.

22.

Developing alternative delivery systems for methacholine challenge tests.

Coates AL, Leung K, Dell SD.

J Aerosol Med Pulm Drug Deliv. 2014 Feb;27(1):66-70. doi: 10.1089/jamp.2013.1036. Epub 2013 Apr 15.

PMID:
23586502
23.

Modeling breath-enhanced jet nebulizers to estimate pulmonary drug deposition.

Wee WB, Leung K, Coates AL.

J Aerosol Med Pulm Drug Deliv. 2013 Dec;26(6):387-96. doi: 10.1089/jamp.2012.0984. Epub 2013 Mar 19.

PMID:
23509934
24.

Spirometry in primary care.

Coates AL, Graham BL, McFadden RG, McParland C, Moosa D, Provencher S, Road J; Canadian Thoracic Society.

Can Respir J. 2013 Jan-Feb;20(1):13-21. Erratum in: Can Respir J. 2013 Mar-Apr;20(2):122.

25.

Children should not be treated like little adults in the PFT lab.

Seed L, Wilson D, Coates AL.

Respir Care. 2012 Jan;57(1):61-70; discussion 71-74. doi: 10.4187/respcare.01430. Review.

26.

Canadian Thoracic Society Pulmonary Function Standards Committee.

Coates AL.

Can Respir J. 2011 Nov-Dec;18(6):320. No abstract available.

27.

Using reference values to interpret pulmonary function tests.

Coates AL.

Paediatr Respir Rev. 2011 Sep;12(3):206-7. doi: 10.1016/j.prrv.2011.01.012. Review. No abstract available.

PMID:
21722850
28.

Presentation and treatment of monozygotic twins with congenital central hypoventilation syndrome.

Amin R, Riekstins A, Al-Saleh S, Massicotte C, Coates AL, MacLusky I.

Can Respir J. 2011 Mar-Apr;18(2):87-9.

29.

Higher tobramycin concentration and vibrating mesh technology can shorten antibiotic treatment time in cystic fibrosis.

Coates AL, Denk O, Leung K, Ribeiro N, Chan J, Green M, Martin S, Charron M, Edwardes M, Keller M.

Pediatr Pulmonol. 2011 Apr;46(4):401-8. doi: 10.1002/ppul.21376. Epub 2010 Dec 30.

PMID:
21438171
30.

A comparison of amount and speed of deposition between the PARI LC STAR® jet nebulizer and an investigational eFlow® nebulizer.

Coates AL, Green M, Leung K, Chan J, Ribeiro N, Ratjen F, Charron M.

J Aerosol Med Pulm Drug Deliv. 2011 Jun;24(3):157-63. doi: 10.1089/jamp.2010.0861. Epub 2011 Mar 1.

PMID:
21361784
31.

Testing of nebulizers for delivering magnesium sulfate to pediatric asthma patients in the emergency department.

Coates AL, Leung K, Vecellio L, Schuh S.

Respir Care. 2011 Mar;56(3):314-8. doi: 10.4187/respcare.00826. Epub 2010 Nov 16.

32.

Skeletal muscle metabolism in cystic fibrosis and primary ciliary dyskinesia.

Wells GD, Wilkes DL, Schneiderman JE, Rayner T, Elmi M, Selvadurai H, Dell SD, Noseworthy MD, Ratjen F, Tein I, Coates AL.

Pediatr Res. 2011 Jan;69(1):40-5. doi: 10.1203/PDR.0b013e3181fff35f.

PMID:
20938370
33.

Readministration of helper-dependent adenoviral vectors to mouse airway mediated via transient immunosuppression.

Cao H, Yang T, Li XF, Wu J, Duan C, Coates AL, Hu J.

Gene Ther. 2011 Feb;18(2):173-81. doi: 10.1038/gt.2010.125. Epub 2010 Sep 30.

PMID:
20882053
34.

Performance of PARI eFlow.

Coates AL.

J Aerosol Med Pulm Drug Deliv. 2010 Apr;23(2):114; author reply 114-8. doi: 10.1089/jamp.2009.Cor2. No abstract available.

PMID:
20384518
35.

Exercise capacity of children with pediatric lung disease.

Zavorsky GS, Kryder JR, Jacob SV, Coates AL, Davis GM, Lands LC.

Clin Invest Med. 2009 Dec 1;32(6):E302.

PMID:
20003836
36.

Exercise and physical activity in children with cystic fibrosis.

Wilkes DL, Schneiderman JE, Nguyen T, Heale L, Moola F, Ratjen F, Coates AL, Wells GD.

Paediatr Respir Rev. 2009 Sep;10(3):105-9. doi: 10.1016/j.prrv.2009.04.001. Epub 2009 Jul 21. Review.

PMID:
19651380
37.

Transmission of influenza virus via aerosols and fomites in the guinea pig model.

Mubareka S, Lowen AC, Steel J, Coates AL, García-Sastre A, Palese P.

J Infect Dis. 2009 Mar 15;199(6):858-65.

38.

Age- and size-related reference ranges: a case study of spirometry through childhood and adulthood.

Cole TJ, Stanojevic S, Stocks J, Coates AL, Hankinson JL, Wade AM.

Stat Med. 2009 Feb 28;28(5):880-98. doi: 10.1002/sim.3504. Erratum in: Stat Med. 2009 May 15;28(11):1644.

39.

Assessment of body composition in pediatric patients with cystic fibrosis.

Wells GD, Heale L, Schneiderman JE, Wilkes DL, Atenafu E, Coates AL, Ratjen F.

Pediatr Pulmonol. 2008 Oct;43(10):1025-32. doi: 10.1002/ppul.20913.

PMID:
18781652
40.

Burkholderia pseudomallei infection in a cystic fibrosis patient from the Caribbean: a case report.

Corral DM, Coates AL, Yau YC, Tellier R, Glass M, Jones SM, Waters VJ.

Can Respir J. 2008 Jul-Aug;15(5):237-9.

41.

A single versus multiple doses of dexamethasone in infants wheezing for the first time.

Schuh S, Coates AL, Dick P, Stephens D, Lalani A, Nicota E, Mokanski M, Khaikin S, Allen U.

Pediatr Pulmonol. 2008 Sep;43(9):844-50. doi: 10.1002/ppul.20845.

PMID:
18668692
42.

Rapid pulmonary delivery of inhaled tobramycin for Pseudomonas infection in cystic fibrosis: a pilot project.

Coates AL, Green M, Leung K, Chan J, Ribeiro N, Louca E, Ratjen F, Charron M, Tservistas M, Keller M.

Pediatr Pulmonol. 2008 Aug;43(8):753-9. doi: 10.1002/ppul.20850.

PMID:
18613006
43.

Reliability and validity of the habitual activity estimation scale (HAES) in patients with cystic fibrosis.

Wells GD, Wilkes DL, Schneiderman-Walker J, Elmi M, Tullis E, Lands LC, Ratjen F, Coates AL.

Pediatr Pulmonol. 2008 Apr;43(4):345-53. doi: 10.1002/ppul.20737.

PMID:
18306334
44.

Guiding aerosol deposition in the lung.

Coates AL.

N Engl J Med. 2008 Jan 17;358(3):304-5. doi: 10.1056/NEJMcibr0707489. No abstract available.

PMID:
18199871
45.

Reference ranges for spirometry across all ages: a new approach.

Stanojevic S, Wade A, Stocks J, Hankinson J, Coates AL, Pan H, Rosenthal M, Corey M, Lebecque P, Cole TJ.

Am J Respir Crit Care Med. 2008 Feb 1;177(3):253-60. Epub 2007 Nov 15.

46.

The challenges of quantitative measurement of lung deposition using 99mTc-DTPA from delivery systems with very different delivery times.

Coates AL, Green M, Leung K, Louca E, Tservistas M, Chan J, Ribeiro N, Charron M.

J Aerosol Med. 2007 Fall;20(3):320-30.

PMID:
17894538
47.

Calculating expected lung deposition of aerosolized administration of AAV vector in human clinical studies.

Leung K, Louca E, Munson K, Dutzar B, Anklesaria P, Coates AL.

J Gene Med. 2007 Jan;9(1):10-21.

PMID:
17154340
48.

High-dose inhaled fluticasone does not replace oral prednisolone in children with mild to moderate acute asthma.

Schuh S, Dick PT, Stephens D, Hartley M, Khaikin S, Rodrigues L, Coates AL.

Pediatrics. 2006 Aug;118(2):644-50.

PMID:
16882819
49.

Comparison of three valved holding chambers for the delivery of fluticasone propionate-HFA to an infant face model.

Louca E, Leung K, Coates AL, Mitchell JP, Nagel MW.

J Aerosol Med. 2006 Summer;19(2):160-7.

PMID:
16796540
50.

Nebulized therapies for childhood pulmonary hypertension: an in vitro model.

Katz SL, Adatia I, Louca E, Leung K, Humpl T, Reyes JT, Coates AL.

Pediatr Pulmonol. 2006 Jul;41(7):666-73.

PMID:
16703580

Supplemental Content

Loading ...
Support Center